Rapport Therapeutics disclosed a stock sale in an SEC filing and is listed on Nasdaq.
1 report, 1 independent
Updated Fri 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rapport Therapeutics disclosed a stock sale in an SEC filing and is listed on Nasdaq.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Monopar Therapeutics stock traded on the Nasdaq exchange and disclosed transactions via SEC filings on October 5, 2026.
- Pro-Dex, Inc. was listed on the Nasdaq stock exchange and disclosed a transaction via a legal filing with the SEC.
- RxSight disclosed a sale via SEC filing and is listed on Nasdaq.
- Capricor Therapeutics disclosed insider trading filings with the SEC and was listed on the Nasdaq stock exchange.
- Universal Electronics Inc. disclosed a transaction in a legal filing with the SEC and its stock is traded on the Nasdaq exchange.